表紙
市場調查報告書
商品編碼
967207

手術部位感染管理的北美市場:未來預測 (2021年∼2028年)

North America Surgical Site Infection Control Market Forecast 2021-2028

出版日期: | 出版商: Inkwood Research | 英文 144 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

北美的手術部位感染管理市場,預計2021年∼2028年5.49%的年複合成長率進化。尤其是近來,新型冠狀病毒感染疾病 (COVID-19)的感染率的上升促進市場成長。

本報告提供北美各國 (美國,加拿大)的手術部位感染管理的市場相關分析,市場基本結構和主要的促進、阻礙因素,市場規模趨勢預測 (過去3年、今後9年份),治療、感染的各類型、各終端用戶、各產品及各地區詳細趨勢,市場競爭趨勢,主要企業的簡介 (企業概要,主要產品/服務,事業策略,最新趨勢及其他) 等相關調查。

目錄

第1章 調查範圍、手法

第2章 摘要整理

第3章 市場動態

  • 主要的推動市場要素
    • 手術率的上升
    • 老年人口的劇增
    • 為了預防院內感染的法規指南的實施
    • 院內感染的發生率增加
  • 主要的阻礙市場要素
    • 由於醫療用拋棄式用品的利用,醫療廢棄物劇增
    • 在門診病人治療的使用增加

第4章 主要分析

  • 波特的五力分析
  • COVID-19對手術部位感染管理市場的影響
  • 市場機會矩陣
  • 業者情勢
  • 主要的投資的考察

第5章 各治療的市場

  • 腹腔鏡檢驗
  • 整形外科
  • 心血管
  • 婦產科
  • 傷口縫合
  • 美容、重組手術
  • 胸部外科
  • 微小血管
  • 泌尿科
  • 腦神經外科
  • 其他

第6章 感染的各種類的市場

  • 皮膚表層切口的SSI (手術部位感染)
  • 解剖部深層的SSI
  • 內臟器官、體腔的SSI

第7章 各終端用戶的市場

  • 醫院
  • 門診外科中心

第8章 各產品的市場

  • 消毒劑
  • 手動式清洗液
  • 外科用覆蓋巾
  • 外科用手套
  • 皮膚用消毒液
  • 手術用灌注設備
  • 手術用擦洗
  • 理髮推剪
  • 醫療用不織布
  • 其他的產品

第9章 地區分析

  • 北美
    • 市場規模,估計值
    • 主要的成長實現要素
    • 主要課題
    • 主要企業
    • 各國分析

第10章 競爭情形

  • 主要策略的發展情形
    • 企業合併、收購 (M&A)
    • 產品銷售、開發
    • 事業聯盟、合作,契約/協定
    • 事業擴大/核准/發表
  • 企業簡介
    • 3M COMPANY
    • AMERICAN POLYFILM
    • ANSELL LTD
    • BECTON, DICKINSON AND COMPANY (BD)
    • BELIMED AG
    • BIOMERIEUX SA
    • GAMA HEALTHCARE
    • GETINGE AB
    • JOHNSON & JOHNSON
    • KIMBERLY-CLARK
    • LAC-MAC
    • PACON MANUFACTURING CORPORATION
    • SOTERA HEALTH LLC
    • STERIS CORPORATION
    • STRYKER CORPORATION
目錄
Product Code: 34482

KEY FINDINGS

The North America surgical site infection control market is anticipated to evolve with a CAGR of 5.49%, during the forecast period of 2021 to 2028. The region's market growth is fueled by factors like, the rising rate of infection, mainly owing to the COVID-19 outbreak, and the prevention program for surgical site infections.

MARKET INSIGHTS

The North America surgical site infection control market growth includes analyzing Canada and the United States. Despite Canada's advancements in aseptic techniques, less invasive surgical techniques, and antibiotic prophylaxis, healthcare-associated infections continue complicating the recovery of numerous surgical patients. According to the Canadian Patient Safety Institute (ICSP), surgical site infections are among the most common healthcare-associated conditions observed in patients that have undergone surgery, with nearly 77% of fatalities reportedly linked to an infection. Moreover, as per the Centers for Disease Control, surgical site infections continue to remain a significant cause of death, morbidity, and extended hospitalizations in the country, irrespective of the improvements made in infection control practices.

On the other hand, Safer Healthcare Now!, introduced the SSI Getting Started Kit, in 2005. Since then, the data regarding self-reported surgical site infection prevention processes, by 145 organizations across Canada, have been recorded. As a result, there has been a significant decline in surgical site infection rates, particularly in clean and clean-contaminated surgeries, from 2005 to 2020. Hence, these factors are accredited to driving the surgical site infection control market growth, over the forecast years.

COMPETITIVE INSIGHTS

Prominent enterprises operating in the market include, Johnson & Johnson, 3M Company, Steris Corporation, Kimberly-Clark, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING RATE OF SURGERIES
    • 3.1.2. SURGE IN GERIATRIC POPULATION
    • 3.1.3. IMPLEMENTATION OF REGULATORY GUIDELINES FOR THE PREVENTION OF HOSPITAL ACQUIRED INFECTION
    • 3.1.4. INCREASED INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. SURGING MEDICAL WASTE DUE TO THE USE OF MEDICAL DISPOSABLE ITEMS
    • 3.2.2. RISE IN THE USE OF OUTPATIENT TREATMENTS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON SURGICAL SITE INFECTION CONTROL MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PROCEDURE

  • 5.1. LAPAROSCOPY
  • 5.2. ORTHOPEDIC SURGERY
  • 5.3. CARDIOVASCULAR
  • 5.4. OBSTETRICS AND GYNECOLOGY
  • 5.5. WOUND CLOSURE
  • 5.6. PLASTIC & RECONSTRUCTIVE SURGERY
  • 5.7. THORACIC SURGERY
  • 5.8. MICROVASCULAR
  • 5.9. UROLOGY
  • 5.10. NEUROSURGERY
  • 5.11. OTHER PROCEDURES

6. MARKET BY TYPE OF INFECTION

  • 6.1. SUPERFICIAL INCISIONAL SSI
  • 6.2. DEEP INCISIONAL SSI
  • 6.3. ORGAN OR SPACE SSI

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. MARKET BY PRODUCT

  • 8.1. DISINFECTANTS
  • 8.2. MANUAL REPROCESSORS SOLUTION
  • 8.3. SURGICAL DRAPES
  • 8.4. SURGICAL GLOVES
  • 8.5. SKIN PREPARATION SOLUTION
  • 8.6. SURGICAL IRRIGATION
  • 8.7. SURGICAL SCRUBS
  • 8.8. HAIR CLIPPERS
  • 8.9. MEDICAL NONWOVENS
  • 8.10. OTHER PRODUCTS

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGER & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 10.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 10.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 10.2. COMPANY PROFILES
    • 10.2.1. 3M COMPANY
    • 10.2.2. AMERICAN POLYFILM
    • 10.2.3. ANSELL LTD
    • 10.2.4. BECTON, DICKINSON AND COMPANY (BD)
    • 10.2.5. BELIMED AG
    • 10.2.6. BIOMERIEUX SA
    • 10.2.7. GAMA HEALTHCARE
    • 10.2.8. GETINGE AB
    • 10.2.9. JOHNSON & JOHNSON
    • 10.2.10. KIMBERLY-CLARK
    • 10.2.11. LAC-MAC
    • 10.2.12. PACON MANUFACTURING CORPORATION
    • 10.2.13. SOTERA HEALTH LLC
    • 10.2.14. STERIS CORPORATION
    • 10.2.15. STRYKER CORPORATION

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SURGICAL SITE INFECTION CONTROL
  • TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER, 2019 AND 2050
  • TABLE 3: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 12: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 13: LEADING PLAYERS OPERATING IN NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET

LIST OF FIGURES

  • FIGURE 1: COMMON TYPES OF HAIS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, IN 2020
  • FIGURE 7: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2021-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, IN 2020
  • FIGURE 19: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2021-2028 (IN $ MILLION)
  • FIGURE 22: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY END-USER, IN 2020
  • FIGURE 23: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2021-2028 (IN $ MILLION)
  • FIGURE 25: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, IN 2020
  • FIGURE 26: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2021-2028 (IN $ MILLION)
  • FIGURE 27: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTION, 2021-2028 (IN $ MILLION)
  • FIGURE 28: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2021-2028 (IN $ MILLION)
  • FIGURE 29: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2021-2028 (IN $ MILLION)
  • FIGURE 30: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTION, 2021-2028 (IN $ MILLION)
  • FIGURE 31: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2021-2028 (IN $ MILLION)
  • FIGURE 32: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2021-2028 (IN $ MILLION)
  • FIGURE 33: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2021-2028 (IN $ MILLION)
  • FIGURE 34: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2021-2028 (IN $ MILLION)
  • FIGURE 35: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)
  • FIGURE 36: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 37: UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: CANADA SURGICAL SITE INFECTION CONTROL MARKET, 2021-2028 (IN $ MILLION)